Insider · CIK 0002017749
Junyuan Jerry Wang
Files at NUVB (Nuvation Bio Inc.). First filing Nov 13, 2024, latest Nov 13, 2024.
Junyuan Jerry Wang files SEC Form 4 as CEO and director at NUVB (Nuvation Bio Inc.). Since Nov 13, 2024, Junyuan Jerry Wang has reported 0 open-market buys worth $0 and 1 open-market sell worth $163k, the latest filed on Nov 13, 2024.
A track record needs three past buys with six months of prices behind them; Junyuan Jerry Wang has 0, so none is measured yet.
The newest scored trade: sold $163k of NUVB on Nov 11, 2024, filed Nov 13, 2024, scored 36 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NUVB: Nuvation Bio Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 11, 2024 | NUVB Nuvation Bio Inc. | SOpen-market sale Class A Common Stock | -56,361 | $2.89 | $163k | 3,866,228 | Nov 13, 2024 |
Questions about Junyuan Jerry Wang
Answered from the filings on this page, as of the latest one.
Is Junyuan Jerry Wang buying or selling?
Not in the last 12 months. Junyuan Jerry Wang's latest open-market trade on SEC Form 4 was sold $163k of NUVB on Nov 11, 2024.
How did Junyuan Jerry Wang's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Junyuan Jerry Wang has 0.
Where does Junyuan Jerry Wang file Form 4?
Junyuan Jerry Wang has filed Form 4 at NUVB (Nuvation Bio Inc.) as CEO, ANHEART THERAPEUTICS LTD.. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.